Moteur de recherche d’entreprises européennes

Financement de l’UE (1 039 600 €) : L’innovation dans la lutte contre la tuberculose Hor13/11/2018 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

L’innovation dans la lutte contre la tuberculose

The objective of INNOVA4TB is to enhance and strengthen the collaborative research among sectors and to form a network aimed to perform high-quality and translational research in the field of diagnosis and management of tuberculosis (TB). The consortium is constituted by 12 institutions from 8 countries that combine complementary and synergic expertise: clinical management (hospitals), basic science and new technologies (academic institutions), and industrial development and entrepreneurship culture (SMEs). The exchanges between the institutions allow the participants to progress in their career perspectives. TB is one of the major infectious diseases worldwide, and the emergence and spread of drug resistant cases is a public health threat. However, the conventional methods used for diagnosis and drug-susceptibility testing are not enough for controlling the disease. In addition, all TB patients, independently of their age, gender, severity of the disease and type of responsible strain, follow the same treatment duration (up to 20 months in drug resistant cases), which often leads to high frequency of adverse events, suboptimal adherence to treatment, and poor outcome. A transition from programmatic to personalized management of TB is needed. Our proposal will develop innovative technologies and approaches in order to improve the individual risk assessment for TB development, to rapidly diagnose active TB, to detect the drug susceptibility of the strain, to design tailor-made therapies, and to use biomarkers to guide and individualize the duration of antimicrobial therapy. This is of great importance for improving the quality of life of patients and ensuring treatment success, as well as for economic reasons for the healthcare system.


Universidad DE LA Frontera ?
Asociacion Centro de Investigacion CRL en Biomateriales- Cic biomaGUNE 13 800,00 €
Consorcio Centro de Investigacion Biomedica en Red M.P 27 600 €
Empe Diagnostics AB 23 092 €
Genome Identification Diagnostics GmbH 23 782 €
Institut de Investigacio en Ciencies de La Salut Germans Trias i Pujol 327 106 €
Institutia Medico-Sanitara Publica - Institutul DE Pneumologie Chiril Draganiuc 73 600 €
Instituto Aragones de Ciencias de La Salud 13 800,00 €
Komunalne Nekomershchyne Pridpryemstvo Odeskyy Oblasnyy Tsentr Sotsialno Znachuchykh Khvorob Odeskoi Oblasnoy Rady 181 746 €
Magritek GmbH 0,00 €
Odeskiy Nacionalniy Universitet Imeni I.I. Mechnikova 78 844 €
Servicios Clinicos SA 55 200 €
Umea Universitet 92 230 €
Universidad de Zaragoza 32 200 €
Universidad Politecnica de Madrid 18 400,00 €
Vinnytsia National M.I. Pyrogov Medical University 78 200 €

https://cordis.europa.eu/project/id/823854

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Universidad de La Frontera, Temuco, Chili.